Ikarian Capital, LLC - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 40 filers reported holding SOLENO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$29,000
-42.0%
128,454
+5.6%
0.00%
-42.9%
Q4 2021$50,000
-55.4%
121,6940.0%0.01%
-12.5%
Q3 2021$112,000
-20.0%
121,694
-0.6%
0.01%
-27.3%
Q2 2021$140,000
-9.7%
122,4620.0%0.01%
+120.0%
Q1 2021$155,000
-34.3%
122,4620.0%0.01%
-50.0%
Q4 2020$236,000
-95.9%
122,462
-95.2%
0.01%
-97.8%
Q2 2020$5,696,0002,565,6010.45%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$22,769,0006.37%
CVI Holdings, LLC 1,550,960$3,443,0001.28%
ORACLE INVESTMENT MANAGEMENT INC 3,670,384$8,148,0001.03%
Trellus Management Company, LLC 366,432$813,0000.88%
AWM Investment Company, Inc. 1,550,000$3,441,0000.60%
Samsara BioCapital, LLC 750,000$1,665,0000.54%
Nantahala Capital Management 7,426,368$16,487,0000.50%
Consonance Capital Management LP 3,040,000$6,749,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 1,233,676$2,739,0000.26%
Granite Point Capital Management, L.P. 2,200,000$4,884,0000.25%
View complete list of SOLENO THERAPEUTICS INC shareholders